Skip to main content

Table 2 Cancer treatment characteristics and bivariate test of association with SF-36 Physical Component Summary (PCS) and Mental Component Summary (MCS) Scores (N = 331)

From: Co-morbidity and predictors of health status in older rural breast cancer survivors

Characteristic

n (%)

SF-36 PCS,

SF-36 MCS,

mean (SD)

mean (SD)

Months since end of treatment *

 

P = 0.709

P = 0.091

≤12

66 (20.4)

43.84 (11.04)

46.43 (12.59)

13-24

181 (56.1)

45.12 (10.43)

50 (11.49)

25+

76 (23.5)

44.71 (11.27)

49.82 (11)

Surgery received

 

P = 0.941

P = 0.009

Lumpectomy

201 (60.7)

44.81 (11.14)

50.32 (10.88)

Mastectomy

98 (29.6)

44.72 (10.01)

48.94 (11.84)

Bilateral mastectomy

32 (9.7)

44.11 (10.13)

43.59 (14.11)

Chemotherapy

 

P = 0.851

P = 0.004

No

158 (47.7)

44.83 (10.55)

51.17 (11.59)

Yes

173 (52.3)

44.61 (10.86)

47.52 (11.43)

Radiation

 

P = 0.906

P = 0.063

No

97 (29.3)

44.61 (10.16)

47.4 (13.4)

Yes

234 (70.7)

44.76 (10.93)

50.02 (10.78)

Hormonal therapy a

 

P = 0.496

P = 0.446

No

113 (34.1)

44.16 (11.15)

48.59 (13.37)

Yes

218 (65.9)

45.01 (10.47)

49.62 (10.64)

Treatment mix

 

P = 0.184

P = 0.002

Surgery only

50 (15.1)

46.68 (9.7)

50.96 (12.71)

Surgery, chemotherapy

47 (14.2)

42.4 (10.28)

43.61 (13.21)

Surgery, radiation

108 (32.6)

44 (10.86)

51.27 (11.11)

Surgery, chemo, radiation

126 (38.1)

45.42 (10.99)

48.95 (10.41)

  1. Notes: P-values from ANOVA tests; * Counts < 331 due to missing responses;
  2. aOn hormonal treatment at the time the data were collected.